CVC buys 241,843 shares as Recordati stock costs EUR 52.98

Published on 10/13/2026 at 09:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CVC bought 241,843 shares on October 12, 2026 at up to EUR 53.00. Recordati stock costs EUR 52.98 on October 13, 2026, and the offer closes October 23, 2026.

CVC-linked buyers purchased 241,843 Recordati shares on October 12, 2026 at prices up to EUR 53.00.
Recordati stock was at EUR 52.98 at Lang & Schwarz on October 13, 2026 at 9:05 a.m. CEST.
The voluntary offer closes on October 23, 2026, with payment scheduled for November 2, 2026.
First-half 2026 revenue rose 6.6 percent to EUR 1.4 billion, while EBITDA increased 8.8 percent to EUR 540.2 million.

Moderne Pharma-Produktionsanlage mit Edelstahltanks und Glasfassade bei Tageslicht — Recordati S.p.A. (IT0003828271) betreibt moderne Pharma-Produktionsanlagen mit hochwertiger Fertigungstechnik am Firmensitz in Mailand, Italien, Illustration mit AI erstellt.

Recordati stock (ISIN IT0003828271) was at EUR 52.98 at Lang & Schwarz on October 13, 2026 at 9:05 a.m. CEST, while CVC-linked buyers had purchased 241,843 shares at prices up to EUR 53.00 on October 12, 2026. TipRanks reported the transaction and said the buyer held 3.25 percent of Recordati directly after the purchase.

Three bid milestones

On July 29, 2026, Recordati reported first-half revenue of EUR 1.4 billion, up 6.6 percent, while EBITDA rose 8.8 percent to EUR 540.2 million, according to Yahoo Finance. On October 6, 2026, CVC and Groupe Bruxelles Lambert raised the offer from EUR 51.29 to EUR 53.00 per share, as Il Sole 24 ORE reported. On October 12, 2026, the additional 241,843-share purchase took place at up to EUR 53.00.

What does the offer mean for value?

The EUR 53.00 bid sits EUR 0.02 above the Lang & Schwarz price cited here, keeping the takeover terms as the central valuation reference. The offer also includes a EUR 0.71 dividend payment, bringing the stated total consideration to EUR 53.71 per share, according to Il Sole 24 ORE. First-half operating data provide a second valuation anchor: reported net income rose 24.8 percent to EUR 269.7 million, while adjusted net income increased 6.7 percent to EUR 349.9 million, according to Yahoo Finance.

Dates for the tender process

The acceptance period closes on October 23, 2026, and payment is scheduled for November 2, 2026, per Il Sole 24 ORE. A separate market calendar lists the next earnings release for November 9, 2026, while Recordati's investor page identifies the first-half 2026 results as the latest interim reporting milestone.

Stock stays near the offer price

Recordati was trading at EUR 52.98 at Lang & Schwarz on October 13, 2026 at 9:05 a.m. CEST. A Borsa Italiana master-data page identifies the company as Recordati Industria Chimica e Farmaceutica S.p.A., ticker REC.MI, with ISIN IT0003828271 and a EUR 10.8 billion market capitalization as of October 12, 2026.

The further course of trading is shown by the continuously updated real-time quote of Recordati stock.